The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for April 2014 (PDF).
This issue reports an update to the Yellow Card form used for collecting suspected adverse reactions with the aim of improving our understanding of a medicine’s effect during pregnancy. The forms will be update to collect data about a current pregnancy including the date of last menstrual period and expected date of delivery. The "additional information" field can also be used to include any information on previous pregnancies, dates and findings of ultrasonography and the dates when a woman started or stopped taking any other medicines and supplements during pregnancy (including folic acid).
This issue also contains a reminder about drug-name confusions at the point of dispensing. A previous Drug Safety Update highlighted this issue but this issue notes that there have been recent errors relating to bumetanide and buspirone. It is also noted that the packaging of some morphine sulfate products is being updated to better highlight the strength of the medicine on the pack.
Action: Clinicians will find this publication to be a useful review of current issues in drug safety.